Spotlight session: Unlocking the potential of iPSCs for scalable advanced therapies

The versatility of iPSCs makes them a promising foundation for cell-based therapies, but challenges remain in manufacturing, quality control, and regulatory acceptance. This spotlight session explores how iPSCs can drive scalable and clinically relevant therapies while ensuring safety, consistency, and translational fidelity. 

Key takeaways: 

• Examine strategies for scalable iPSC manufacturing and differentiation. 

• Evaluate quality control frameworks that ensure safety and reproducibility. 

• Explore how iPSCs can improve accessibility of advanced therapies. 

• Discuss translational fidelity and predictive validity considerations for iPSC-derived products. 

• Consider regulatory perspectives and implementation challenges for iPSC-based therapies.